Stocktoria
UNITEDHEALTH GROUP INC UNH
UNITEDHEALTH GROUP INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.6B | $400.3B | $371.6B | $324.2B | $287.6B | $257.1B | $242.2B | $226.2B | $201.2B | $184.8B |
| SG&A expense | $59.6B | $53.0B | $54.6B | $47.8B | $42.6B | $41.7B | $35.2B | $34.1B | $29.6B | $28.4B |
| Operating income | $19.0B | $32.3B | $32.4B | $28.4B | $24.0B | $22.4B | $19.7B | $17.3B | $15.2B | $12.9B |
| Interest expense | $4.0B | $3.9B | $3.2B | $2.1B | $1.7B | $1.7B | $1.7B | $1.4B | $1.2B | $1.1B |
| Income tax | $1.9B | $4.8B | $6.0B | $5.7B | $4.6B | $5.0B | $3.7B | $3.6B | $3.2B | $4.8B |
| Net income | $12.1B | $14.4B | $22.4B | $20.1B | $17.3B | $15.4B | $13.8B | $12.0B | $10.6B | $7.0B |
| EPS (diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 |
| Operating cash flow | $19.7B | $24.2B | $29.1B | $26.2B | $22.3B | $22.2B | $18.5B | $15.7B | $13.6B | $9.8B |
| Free cash flow | $16.1B | $20.7B | $25.7B | $23.4B | $19.9B | $20.1B | $16.4B | $13.7B | $11.6B | $8.1B |
| Cash & equivalents | $24.4B | $25.3B | $25.4B | $23.4B | $21.4B | $16.9B | $11.0B | $10.9B | $12.0B | $10.4B |
| Inventory | $3.3B | $3.8B | $2.8B | $3.5B | $2.9B | — | — | — | — | — |
| Total assets | $309.6B | $298.3B | $273.7B | $245.7B | $212.2B | $197.3B | $173.9B | $152.2B | $139.1B | $122.8B |
| Total liabilities | $207.9B | $195.7B | $174.8B | $159.4B | $135.7B | $126.8B | $111.7B | $96.0B | $87.0B | $82.6B |
| Shareholders' equity | $100.1B | $98.3B | $94.4B | $81.5B | $75.0B | $68.3B | $60.4B | $54.3B | $49.8B | $38.2B |
Growth · year-over-year · Revenue CAGR 10.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +11.8% | +7.7% | +14.6% | +12.7% | +11.8% | +6.2% | +7.0% | +12.5% | +8.8% | +17.7% |
| Net income growth | -16.3% | -35.6% | +11.2% | +16.4% | +12.2% | +11.3% | +15.5% | +13.5% | +50.5% | +20.7% |
| EPS growth | -14.7% | -35.0% | +12.7% | +17.1% | +12.8% | +11.9% | +17.6% | +13.7% | +47.9% | +20.6% |
| Free cash flow growth | -22.4% | -19.4% | +9.7% | +17.7% | -1.2% | +22.8% | +20.1% | +17.9% | +43.1% | -1.1% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.